|
Delayed
Nasdaq Stockholm
19:00:00 27/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.44 SEK | +2.21% |
|
-9.37% | -13.98% |
| 08-20 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Synact Pharma reports narrower operating loss | FW |
Stock exchange
Nasdaq Stockholm
SYNACT 19.44 kr
+2.21%
1.92M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| SYNACT | 19.44SEK | +2.21% | 1.92M kr | ||
CBOE
| 19.47SEK | +0.99% | 49.71K kr | ||
|
Deutsche Boerse AG
| 8F8 | 1.756EUR | +2.33% | 0 € | |
|
Börse Stuttgart
| 8F8 | 1.730EUR | +2.49% | 0 € | |
|
CBOE
| 21.45SEK | 0.00% | 0 kr | ||
|
Tradegate
| 8F8 | 1.710EUR | -4.04% | 0 € | |
|
Boerse Muenchen
| 8F8 | 1.758EUR | +1.97% | 0 € |
Quotes 5-day view: SynAct Pharma AB
Delayed Quote Nasdaq Stockholm
| 21/08/2026 | 24/08/2026 | 25/08/2026 | 26/08/2026 | 27/08/2026 | |
|---|---|---|---|---|---|
| Last | SEK 19.84 | SEK 19.00 | SEK 19.66 | SEK 19.02 | SEK 19.44 |
| Volume | 69,317 | 79,321 | 91,565 | 76,380 | 98,705 |
| Change | +2.69% | -4.23% | +3.47% | -3.26% | +2.21% |
| Opening | SEK 19.32 | SEK 19.94 | SEK 19.18 | SEK 19.46 | SEK 19.20 |
| High | SEK 20.00 | SEK 20.00 | SEK 19.94 | SEK 19.88 | SEK 19.76 |
| Low | SEK 19.14 | SEK 18.74 | SEK 19.10 | SEK 18.98 | SEK 19.20 |
Performance
| 1 day | +2.21% | ||
| 1 week | -9.37% | ||
| Current month | +6.46% | ||
| 1 month | +6.46% | ||
| 3 months | +35.19% | ||
| 6 months | -0.82% | ||
| Current year | -13.98% | ||
| 1 year | +8.85% | ||
| 3 years | -80.34% | ||
| 5 years | -83.38% | ||
| 10 years | +201.40% |
Volumes
marketsDaily volume
98,705
Estimated daily volume
99,802
Avg. Volume 20 sessions
139,857
Daily volume ratio
0.71
Avg. Volume 20 sessions SEK
2,718,820.08
Avg. Volume 20 sessions USD
285,791.49
Record volume 1
8,543,127
Record volume 2
8,361,601
Record volume 3
6,485,499
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (SEK)
1,063,149,907
Market Cap (USD)
111,717,774
Net sales (SEK)
0
Net sales (USD)
0
Number of employees
8
Sales / Employee (SEK)
0
Sales / Employee (USD)
0
Free-Float
66.53 %
Free-Float capitalization (SEK)
710,020,477
Free-Float capitalization (USD)
74,610,275
Average Daily Capital Traded
0.26%
Indicators
Moving average 5 days
19.37
Moving average 20 days
19.19
Moving average 50 days
18.4
Moving average 100 days
17.11
Price spread / (MMA5)
-0.37%
Price spread / (MMA20)
-1.27%
Price spread / (MMA50)
-5.33%
Price spread / (MMA100)
-11.99%
STIM
RSI 9 days
51.92
RSI 14 days
52.93
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | -9.37% | +8.85% | -80.34% | 112M | |
| -0.57% | -4.98% | +61.06% | +113.47% | 1,060B | |
| -1.25% | -0.28% | +50.82% | +62.29% | 651B | |
| -1.83% | -1.43% | +24.05% | +75.06% | 465B | |
| -1.17% | -2.10% | +38.61% | +40.46% | 365B | |
| -2.00% | -1.35% | +22.22% | +37.78% | 300B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | |
| -0.14% | +1.32% | +52.60% | +71.29% | 238B | |
| -3.18% | -0.30% | -17.23% | -54.33% | 210B | |
| +0.03% | +3.47% | +30.28% | +92.65% | 184B | |
| Average | -0.83% | -1.73% | +27.33% | +37.05% | 373.05B | |
| Weighted average by Cap. | -1.10% | -2.16% | +38.80% | +66.34% |
Historical Quotes: SynAct Pharma AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a8b0b35105a295c.7m8x5YWy0pRd-Ujybd7O8gPaU7WLQvvgiCzQJklKdTw.qQ5lieiAiPIvqiaQAOybxjubNIP9FoKsx23lZSMEMXbWLXC06Mji_2-9Kw
| Date | Price | Volume | Total |
|---|---|---|---|
| 18:29:58 | 19.44 | 61 | 98,705 |
| 18:29:58 | 19.44 | 179 | 98,644 |
| 18:29:58 | 19.44 | 114 | 98,465 |
| 18:29:58 | 19.44 | 340 | 98,351 |
| 18:29:58 | 19.44 | 747 | 98,011 |
| 18:29:58 | 19.44 | 522 | 97,264 |
| 18:29:58 | 19.44 | 77 | 96,742 |
| 18:29:58 | 19.44 | 350 | 96,665 |
Price Extremes
| 1 week | 18.74 |  | 21.05 |
| 1 month | 17.08 | | 22.2 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
Monthly variations
Annual variations
| 2026 | -15.84% | ||
| 2025 | +152.09% | ||
| 2024 | +1.53% | ||
| 2023 | -89.17% | ||
| 2022 | -42.77% | ||
| 2021 | +221.44% | ||
| 2020 | +446.91% | ||
| 2019 | +21.99% | ||
| 2018 | -37.36% | ||
| 2017 | +82.76% | ||
| 2016 | +11.54% |
- Stock Market
- Stocks
- SYNACT Stock
- Quotes SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
